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The metabolic equivalent (MET) is a widely used physiological concept for quantifying levels of 
habitual physical activity and cardiorespiratory fitness (CRF) by conveying oxygen consumption 
requirements of physical activities as multiples of resting or basal metabolic rate (RMR). It may also 
be used as a means of prescribing workload for exercise training in patient groups, including those 
attending cardiac rehabilitation (CR). One MET is considered equivalent to the oxygen consumed per 
kg of body mass at rest1  (whilst sitting) and, due to practical issues with direct metabolic cart 
measurement, it is conventionally approximated as 3.5 ml∙kg–1∙min–1. This expression of resting 
energy expenditure has been incorporated within physical activity position statements and 
guidelines.2,3 However, a number of factors including age, gender, body mass (fat-free mass), cardio-
metabolic health, and CRF influence RMR,4  which might limit the broad applicability of the 
conventional 1 MET at a population level. Widely prescribed cardiac medications, namely beta 
blockers, have also been cited to influence RMR with some inconsistent findings in males.5 We aimed 
to evaluate the potential limitations of using the estimated MET in a cohort of patients with 
coronary heart disease (CHD), in which we recently reported a positive association between skeletal 
muscle mass and peak oxygen uptake (V̇O2peak).
6 We hypothesised that patients with lower skeletal 
muscle mass would also have lower RMR, determined by resting respiratory gas analysis, and this 
would impact on the accuracy of the aerobic exercise prescription based on METs. 
 
In patients with diagnosed CHD, we measured resting V̇O2 recorded whilst lying for 15 minutes in a 
semi-supine position in a quiet room, following standardised instructions to avoid physical activity 
and limit food intake in the hours prior to testing. Patients’ V̇O2 was continuously recorded using an 
Oxycon Pro metabolic gas cart (Jaeger, Hochberg, Germany). The average V̇O2 over the final 30 
seconds of data collected was reported as the patient’s RMR (ml∙kg–1∙min–1). Dual X‐ray 
absorptiometry scans were conducted as previously reported.6 Skeletal muscle mass was expressed 
as appendicular lean mass (lean mass in both arms and legs) and reported as skeletal muscle index 
(SMI; kg m−2). Maximal cardiopulmonary exercise testing using the modified Bruce protocol was 
  
conducted as previously reported.6 V̇O2 was recorded over the last 30 seconds of each test stage, 
and the final 30 seconds of the symptom limited or maximal tolerance test (V̇O2peak). The V̇O2 at the 
end of stage one, and at V̇O2peak were divided by 3.5 ml∙kg
–1∙min–1 (reference value for resting MET) 
to establish the estimated MET level of the stage 1 and peak exercise workload. The V̇O2 at the end 
of stage one, and at V̇O2peak were also divided by each patient’s RMR, to establish the true MET 
level of the graded/uphill treadmill walk.  
In 70 patients with CHD (mean ± SD; age 63.1 ± 10.0 years; male 86%; body mass 84.7 ± 13.4 kg), 
resting, semi-supine V̇O2 was lower than 3.5 ml∙kg
-1∙min-1 (mean resting V̇O2 = 2.8 ±0.5 ml∙kg
-1∙min-1; 
Table 1). This mean RMR is consistent with other studies in apparently healthy elderly men,6 and a 
comparable large cohort of overweight male and female patients (mean MET= 2.58 ± 0.4 ml ∙kg-
1∙min-1) with CHD, which indicated that the 3.5 ml∙kg-1∙min-1 significantly overestimated resting 
oxygen consumption by 30-35%.7 In our study, patients with a normal SMI had a higher resting V̇O2 
(2.9 ± 0.5 ml∙kg-1∙min-1), than patients with a low SMI (resting V̇O2 = 2.6 ± 0.3 ml∙kg
-1∙min-1).   
When calculating exercise-related MET equivalents, if all patients were assumed to have a RMR of 
3.5 ml∙kg–1∙min–1, there was no difference (P=0.208) in the METs required to perform stage 1 of the 
Mod Bruce protocol between the appendicular skeletal mass groups (low SMI group = 3.3 METs; 
normal SMI group = 3.6 METs). However, when a patient’s RMR was used to calculate the true MET 
value, there was a between-group difference in METs required to perform stage 1 of the Bruce 
protocol (low SMI group = 5.0 METs; normal SMI group = 4.1 METs; P=0.049). Moreover, patients 
with low SMI also had a significantly lower V̇O2peak compared to patients with normal SMI. However, 
patients with low SMI were older, with a total lower body mass (Table 1). 
 
In patients with CHD, RMR was 17-26% lower than the estimated MET value of 3.5 ml∙kg-1∙min-1. 
These findings are similar to those of Savage and co-workers5 who showed that supine RMR was 23-
36% lower, in overweight, and healthy weight patients with CHD. Our findings have important 
implications for exercise prescription in patients with CHD. If RMR is estimated at 3.5 ml∙kg–1∙min–1, 
  
the intensity of walking over flat ground, at 2.7 km.h-1 (stage 1 of the modified Bruce protocol) is 3.3 
METs. However, this activity is almost 4x resting RMR in CHD patients with normal SMI, and almost 
5x RMR in CHD patients with low SMI. Based on these findings we conclude that the relative 
intensity of physical activity is underestimated based on a conventional MET, particularly in those 
with lower appendicular skeletal muscle mass. It may therefore be inappropriate to estimate the 
intensity of exercise using existing reference values in these patients. 
 
Further examples of how RMR can influence individual exercise prescription are as follows; If a 
patient has an RMR of 3.5 ml∙kg-1∙min-1, an exercise performed at an workload requiring a V̇O2 of 18 
ml∙kg–1∙min–1 would be five times their RMR (5.1 METs).2 However, an individual with a RMR of 2.6 
ml∙kg–1∙min–1 (mean value in our patients with low SMI), performing the same activity would be 
performing it at nearly seven times their RMR, and at a vigorous intensity (6.9 METs; vigorous PA 
defined as >6 METs).2  
 
Further issues arising from individual differences in RMR relate to the use of predictive equations 
when prescribing exercise dose. For example, the ACSM metabolic equation for walking uses the 
estimated resting MET value.3 Using this established ACSM equation to estimate CRF in our patient 
cohort would mean that estimated V̇O2peak was 3.4% lower than actual peak V̇O2. This difference is 
10.6% lower in patients with low SMI. This observation implies that patients with a low SMI would 
undertake a relatively higher dose of exercise if they were prescribed exercise as a percentage of 
their estimated V̇O2peak. Prescribing a higher a dose of exercise makes standardising exercise-based 
research studies more challenging; negatively impacting intervention compliance, and may 
potentially lead to increased safety concerns in these patients. We propose that accounting for 
individualised differences in lean mass/SMI when prescribing exercise dose may be a relevant 
consideration when defining CRF or prescribing exercise intensity in patients with CHD (using the 
METs concept). Whilst direct measurement of RMR is not possible in most exercise-based CR 
  
programmes, skeletal muscle mass and RMR could be estimated with sufficient accuracy using 
bioelectrical impendence analysis/validated MET equations to identify patients with low RMR and/or 
SMI,10 which would allow exercise prescription to be  adjusted accordingly. 
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